T Cell Activators Exhibit Distinct Downstream Effects on Chimeric Antigen Receptor T Cell Phenotype and Function
ImmunoHorizons · 2024
DOI: 10.4049/immunohorizons.2400008 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoHorizons, 2024. Verfasst von Sarah Underwood und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Lymphocyte Activation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
T cell activation is an essential step in chimeric Ag receptor (CAR) T (CAR T) cell manufacturing and is accomplished by the addition of activator reagents that trigger the TCR and provide costimulation. We explore several T cell activation reagents and examine their effects on key attributes of CAR T cell cultures, such as activation/exhaustion markers, cell expansion, gene expression, and transduction efficiency. Four distinct activators were examined, all using anti-CD3 and anti-CD28, but incorporating different mechanisms of delivery: Dynabeads (magnetic microspheres), TransAct (polymeric nanomatrix), Cloudz (alginate hydrogel), and Microbubbles (lipid membrane containing perfluorocarbon gas). Clinical-grade lentiviral vector was used to transduce cells with a bivalent CD19/CD22 CAR, and cell counts and flow cytometry were used to monitor the cells throughout the culture. We observed differences in CD4/CD8 ratio when stimulating with the Cloudz activator, where there was a significant skewing toward CD8 T cells. The naive T cell subset expressing CD62L+CCR7+CD45RA+ was the highest in all donors when stimulating with Dynabeads, whereas effector/effector memory cells were highest when using the Cloudz. Functional assays demonstrated differences in killing of target cells and proinflammatory cytokine secretion, with the highest killing from the Cloudz-stimulated cells among all donors. This study demonstrates that the means by which these stimulatory Abs are presented to T cells contribute to the activation, resulting in differing effects on CAR T cell function. These studies highlight important differences in the final product that should be considered when manufacturing CAR T cells for patients in the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
- Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
ORCID-Profile: Lipei Shao, Hannah W Song
Förderung
- Intramural NIH HHS
Zitieren
APA
Underwood, S., Jin, J., Shao, L., Prochazkova, M., Shi, R., Song, H. W., Jin, P., Shah, N. N., Somerville, R. P., Stroncek, D. F., & Highfill, S. L. (2024). T Cell Activators Exhibit Distinct Downstream Effects on Chimeric Antigen Receptor T Cell Phenotype and Function. ImmunoHorizons. https://doi.org/10.4049/immunohorizons.2400008
Vancouver
Underwood S, Jin J, Shao L, Prochazkova M, Shi R, Song HW, et al. T Cell Activators Exhibit Distinct Downstream Effects on Chimeric Antigen Receptor T Cell Phenotype and Function. ImmunoHorizons. 2024. doi:10.4049/immunohorizons.2400008
BibTeX
@article{Underwood2024,
author = {Underwood, Sarah and Jin, Jianjian and Shao, Lipei and Prochazkova, Michaela and Shi, Rongye and Song, Hannah W and Jin, Ping and Shah, Nirali N and Somerville, Robert P and Stroncek, David F and Highfill, Steven L},
title = {T Cell Activators Exhibit Distinct Downstream Effects on Chimeric Antigen Receptor T Cell Phenotype and Function},
journal = {ImmunoHorizons},
year = {2024},
doi = {10.4049/immunohorizons.2400008}
}
EUVIMED